TREATMENT WITH RUXOLITINIB IN MYELOFIBROSIS AND VERA POLYTETHEMIA: EXPERIENCE IN A COMARCAL HOSPITAL

被引：0
|
作者：
Mas Esteve, E. [1 ]
Claros Barrachina, N. [1 ]
Bernat Pablo, S. [1 ]
Guinot Martinez, M. [1 ]
机构：
[1] Hosp Univ La Plana Vila Real, Villarreal, Spain
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB- 096
引用
收藏
页码：357 / 358
页数：2
相关论文
共 50 条
  • [1] TREATMENT WITH RUXOLITINIB IN MYELOFIBROSIS AND POLYCYTHEMIA VERA EXPERIENCE OF A CENTRE
    Moya Arnao, M.
    Perez Lopez, R.
    Martinez Marin, A.
    Fernandez Poveda, E.
    Navarro Almenzar, B.
    Berenguer Piqueras, M.
    Cabanas Perianes, V
    Salido Fierez, E.
    Moreno Belmonte, M. J.
    Cerezo Manchado, J. J.
    Labbadia, F.
    Blanquer Blanquer, M.
    Garcia Hernandez, A. M.
    Martinez Garcia, A. B.
    Melero Amor, A.
    Rosique Cortina, P.
    Ruiz Sanchez, M.
    Moraleda Jimenez, J. M.
    HAEMATOLOGICA, 2017, 102 : 332 - 333
  • [2] Experience with ruxolitinib in the treatment of polycythaemia vera
    Alimam, Samah
    Harrison, Claire
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (04) : 139 - 151
  • [3] Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib
    Bryan, Jeffrey C.
    Verstovsek, Srdan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1125 - 1142
  • [4] Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib
    Jeffrey C. Bryan
    Srdan Verstovsek
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1125 - 1142
  • [5] Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantation
    Dold, Leona
    Lutz, Philipp
    Heine, Annkristin
    Weismuller, Tobias J.
    Strassburg, Christian P.
    Spengler, Ulrich
    CLINICAL CASE REPORTS, 2021, 9 (09):
  • [6] RUXOLITINIB FOR THE TREATMENT OF MYELOFIBROSIS
    Ostojic, A.
    Vrhovac, R.
    Verstovsek, S.
    DRUGS OF TODAY, 2011, 47 (11) : 817 - 827
  • [7] Ruxolitinib In the Treatment of Myelofibrosis
    Yang, Lily P. H.
    Keating, Gillian M.
    DRUGS, 2012, 72 (16) : 2117 - 2127
  • [8] TREATMENT WITH RUXOLITINIB IN MYELOFIBROSIS: EXPERIENCE AND RESULTS OBTAINED IN OUR FIELD
    Alejandro, Martin-Martin
    Dolly, Fiallo
    Hector, Gonzalez-Mendez
    Melania, Moreno-Vega
    Nuria, Hernanz
    Maria Jose, Rodriguez-Salazar
    Gloria, Gonzalez-Brito
    Maria, Perera
    Teresa, Molero
    Miguel Teodoro, Hernandez-Garcia
    Maria Teresa, Gomez-Casares
    Jose Maria, Raya
    HAEMATOLOGICA, 2016, 101 : 345 - 345
  • [9] Ruxolitinib in Myelofibrosis; the Northern Ireland experience
    Daly, A.
    Russell, J.
    Arnold, C.
    Bowers, M.
    Boyd, K.
    Cuthbert, R.
    El-Agnaf, M.
    Elder, P.
    Eswedi, H.
    Finnegan, D.
    Hamilton, J.
    Hull, D.
    McCloskey, S.
    McConville, C.
    McNicholl, F.
    Ong, Y. -L.
    Windrum, P.
    McMullin, M. -F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 61 - 62
  • [10] RUXOLITINIB IN PATIENS WITH MYELOFIBROSIS, ROMAGNA EXPERIENCE
    Salvucci, M.
    Cellini, C.
    Castagnari, N.
    Zanchini, R.
    D'Addio, A.
    Tani, M.
    Daghia, G.
    Lucchesi, A.
    Zumaglini, F.
    Giannini, B.
    Bagli, L.
    Sensi, A.
    Zuffa, E.
    HAEMATOLOGICA, 2015, 100 : 107 - 107
12345